6-Month Buy/Sell Trend
Buys
Sells
▶
2026-04-07
3 other
▶
2026-04-02
2 other
⚡ 2 insiders
▶
2026-01-26
▼ 1 sell
· $139K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | ▼ Sell | 3,746 | $37 | $139K | Plan | Jan 28 |
▶
2026-01-24
12 other
⚡ 4 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Budur Kumar | CHIEF MEDICAL OFFICER | M | 2,188 | $0 | $0 | Jan 26 | |
| Budur Kumar | CHIEF MEDICAL OFFICER | F | 1,153 | $37 | $42K | Jan 26 | |
| Budur Kumar | CHIEF MEDICAL OFFICER | M | 2,188 | $0 | $0 | Jan 26 | |
| Dayno Jeffrey M. | PRESIDENT, CEO | M | 10,500 | $0 | $0 | Jan 26 | |
| Dayno Jeffrey M. | PRESIDENT, CEO | F | 4,785 | $37 | $176K | Jan 26 | |
| Dayno Jeffrey M. | PRESIDENT, CEO | M | 10,500 | $0 | $0 | Jan 26 | |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | 3,813 | $0 | $0 | Jan 26 | |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | 2,239 | $37 | $82K | Jan 26 | |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | 3,813 | $0 | $0 | Jan 26 | |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M | 2,500 | $0 | $0 | Jan 26 | |
| Serafin Andrew | CHIEF STRATEGY OFFICER | F | 1,116 | $37 | $41K | Jan 26 | |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M | 2,500 | $0 | $0 | Jan 26 |
▶
2026-01-25
12 other
⚡ 4 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Budur Kumar | CHIEF MEDICAL OFFICER | M | 2,662 | $0 | $0 | Jan 26 | |
| Budur Kumar | CHIEF MEDICAL OFFICER | F | 1,372 | $37 | $51K | Jan 26 | |
| Budur Kumar | CHIEF MEDICAL OFFICER | M | 2,662 | $0 | $0 | Jan 26 | |
| Dayno Jeffrey M. | PRESIDENT, CEO | M | 13,000 | $0 | $0 | Jan 26 | |
| Dayno Jeffrey M. | PRESIDENT, CEO | F | 5,654 | $37 | $208K | Jan 26 | |
| Dayno Jeffrey M. | PRESIDENT, CEO | M | 13,000 | $0 | $0 | Jan 26 | |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | 4,725 | $0 | $0 | Jan 26 | |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | F | 2,553 | $37 | $94K | Jan 26 | |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | M | 4,725 | $0 | $0 | Jan 26 | |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M | 2,600 | $0 | $0 | Jan 26 | |
| Serafin Andrew | CHIEF STRATEGY OFFICER | F | 1,126 | $37 | $41K | Jan 26 | |
| Serafin Andrew | CHIEF STRATEGY OFFICER | M | 2,600 | $0 | $0 | Jan 26 |
▶
2026-01-22
10 other
⚡ 5 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Budur Kumar | CHIEF MEDICAL OFFICER | A | 42,600 | $0 | $0 | Jan 26 | |
| Budur Kumar | CHIEF MEDICAL OFFICER | A | 12,200 | $0 | $0 | Jan 26 | |
| Dayno Jeffrey M. | PRESIDENT, CEO | A | 184,600 | $0 | $0 | Jan 26 | |
| Dayno Jeffrey M. | PRESIDENT, CEO | A | 52,900 | $0 | $0 | Jan 26 | |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | 42,600 | $0 | $0 | Jan 26 | |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | A | 12,200 | $0 | $0 | Jan 26 | |
| Serafin Andrew | CHIEF STRATEGY OFFICER | A | 42,600 | $0 | $0 | Jan 26 | |
| Serafin Andrew | CHIEF STRATEGY OFFICER | A | 12,200 | $0 | $0 | Jan 26 | |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A | 56,900 | $0 | $0 | Jan 26 | |
| Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | A | 16,200 | $0 | $0 | Jan 26 |
▶
2026-01-15
▼ 1 sell
· $753K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | ▼ Sell | 20,961 | $36 | $753K | Plan | Jan 20 |
▶
2025-12-12
▼ 2 sells
· $1.0M
2 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Dayno Jeffrey M. | PRESIDENT, CEO | M | 20,000 | $8 | $164K | Plan | Dec 17 |
| Dayno Jeffrey M. | PRESIDENT, CEO | ▼ Sell | 20,000 | $40 | $802K | Plan | Dec 17 |
| Dayno Jeffrey M. | PRESIDENT, CEO | ▼ Sell | 5,933 | $40 | $238K | Plan | Dec 17 |
| Dayno Jeffrey M. | PRESIDENT, CEO | M | 20,000 | $0 | $0 | Plan | Dec 17 |
▶
2025-12-05
▼ 1 sell
· $791K
2 other
▶
2025-11-21
▼ 1 sell
· $120K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | ▼ Sell | 3,427 | $35 | $120K | Plan | Nov 25 |
▶
2025-09-30
3 other
▶
2025-08-28
1 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Valor IV Pharma Holdings, LLC | — | J | 6,618,033 | — | — | Sep 2 |
▶
2025-08-15
▼ 1 sell
· $787K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Kapadia Sandip | CHIEF FINANCIAL OFFICER | ▼ Sell | 21,573 | $36 | $787K | Plan | Aug 19 |
▶
2025-05-15
6 other
⚡ 6 insiders
▶
2025-05-25
1 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Graf R. Mark | — | A | 14,522 | $0 | $0 | May 16 |